Archives of Toxicology
April 1, 2020
Dino Luethi, Matthias E. Liechti
258 citations
Abstract Psychoactive substances with chemical structures or pharmacological profiles that are similar to traditional drugs of abuse continue to emerge on the recreational drug market. Internet vendors may at least temporarily sell these so-called designer drugs without adhering to legal statutes or facing legal consequences. Overall, the mechanism of action and adverse effects of designer...
Current Neuropharmacology
January 23, 2020
S. Ferber, D. Namdar, D. Hen-Shoval et al.
Mood disorders are the most prevalent mental conditions encountered in psychiatric practice. Numerous patients suffering from mood disorders present with treatment-resistant forms of depression, co-morbid anxiety, other psychiatric disorders and bipolar disorders. Standardized essential oils (such as that of Lavender officinalis) have been shown to exert clinical efficacy in treating anxiety...
2020
G. Pearlson
Abstract This chapter describes cannabis use and risk for psychosis, the drug's long-term effects on IQ and the modification of THC-related effects by terpenes. These discussions of cannabis raise much wider issues that apply to the myriad of recreational drugs affecting mood and consciousness from legal everyday examples, such as caffeine, tobacco, and alcohol; through the illegal, including...
Handbook of experimental pharmacology
2020
Kenichi Tamama, Michael J Lynch
Drug use and the associated overdose deaths have been a serious public health threat in the United States and the world. While traditional drugs of abuse such as cocaine remain popular, recreational use of newer synthetic drugs has continued to increase, but the prevalence of use is likely underestimated. In this review, epidemiology, chemistry, pharmacophysiology, clinical effects, laboratory...
European Addiction Research
2020
Franz Moggi, Deborah Schorno, Leila M. Soravia et al.
22 citations
<b><i>Background:</i></b> Attention deficit/hyperactivity disorder (ADHD), conduct disorder (CD), and sensation seeking (SS) have been consistently related to a higher risk of substance use (SU) and substance use disorder (SUD). <b><i>Objectives:</i></b> To investigate the relationship between ADHD and prevalence rates in males at age 20 and age 25, the initiation of SU and SUD after age 20,...
Romanian Journal of Pediatrics
December 31, 2019
Viorela Nițescu
Conform definiiei stabilite de Monitorul European pentru Droguri i Toxicomanie (European Monitoring Centre for Drugs and Drug Addiction -EMCDDA), o "substan psihoactiv nou este considerat orice substan narcotic sau psihotrop n form pur sau n preparate, care nu este controlat prin Conveniile privitoare la droguri ale Naiunilor Unite i care reprezint o ameninare la adresa sntii umane comparabil...
The Lancet Psychiatry
October 28, 2019
N. Black, E. Stockings, G. Campbell et al.
Background: Medicinal cannabinoids, including medicinal cannabis, pharmaceutical cannabinoids and their synthetic derivatives, including tetrahydrocannabinol (THC) and or cannabidiol (CBD), have been suggested to have a therapeutic role for certain mental health conditions. The primary objective was to review the evidence for cannabinoids in treating symptoms of depression, anxiety,...
The American journal of gastroenterology
October 1, 2019
Davood Tarzi, Jyoti Pradhananga
INTRODUCTION: Recreational ketamine abuse can present with a unique constellation of symptoms, and limited literature on this topic makes this case a rare learning opportunity. CASE DESCRIPTION/METHODS: A 37-year-old male with diffuse psoriasis and a one-year-history of ketamine inhalation presented to the ER complaining of recurrent episodes of epigastric pain. The pain was described as...
ACS Omega
September 24, 2019
Meghan Grace Appley, Samira Beyramysoltan, Rabi Ann Musah
18 citations
The United Nations Office on Drugs and Crime has designated several "legal highs" as "plants of concern" because of the dangers associated with their increasing recreational abuse. Routine identification of these products is hampered by the difficulty in distinguishing them from innocuous plant materials such as foods, herbs, and spices. It is demonstrated here that several of these products...
Journal of Psychosocial Nursing and Mental Health Services
September 1, 2019
Andrew Penn
The increasing public acceptance of cannabis and the proliferation of cannabis products in the marketplace has coincided with more patients using the drug as a substitute for psychiatric medications or as an adjunctive treatment modality for psychiatric conditions, despite limited evidence of efficacy. With a goal of furthering harm-reduction efforts in psychiatric nursing, the current article...